Global pharma major Lupin Limited (Lupin) today announced the successful completion of the inspection carried out by the UK Medicines and Healthcare products Regulatory Agency (UK MHRA) at its Pithampur facilities in India. The inspection was conducted from 20th March to 24th March, 2023.
"We are proud that our Pithampur site has been successfully inspected by the MHRA again, highlighting our unwavering commitment to quality and compliance. With the combination of oral solid, inhalation, dermatology, high potent and oral contraceptive products, this is an important facility and maintaining the highest standards of quality and compliance is a must," said Nilesh Gupta, Managing Director, Lupin.
Shares of Lupin Limited was last trading in BSE at Rs. 639.75 as compared to the previous close of Rs. 648.50. The total number of shares traded during the day was 17205 in over 932 trades.
The stock hit an intraday high of Rs. 654.95 and intraday low of 638.55. The net turnover during the day was Rs. 11165870.00.